Glück Z, Beretta-Piccoli C, Reubi F C
Eur J Clin Pharmacol. 1984;26(3):315-23. doi: 10.1007/BF00548761.
The effect of captopril up to 450 mg/day on blood pressure and renal function were investigated during sustained treatment of 10 patients whose severe hypertension had not responded to previous therapy. All the patients were kept on diuretics and most of them on beta-blockers, too. A control determination of glomerular filtration rate (GFR) and para-aminohippuric acid clearance (CPAH) was performed during the prior treatment. The effect of the addition (or substitution) of captopril were assessed after an average of 25 days (short-term) and 26 weeks (long-term). Short-term treatment produced a 15.5% decrease in mean blood pressure and interindividually variable effects on renal function. On average GFR was somewhat lower and CPAH slightly higher than the control values (not significant). This pattern is quite similar to the effects of most other antihypertensive drugs. On long-term therapy GFR rose by a mean of 9% (NS) and CPAH by 17% (p less than 0.02). However, in a patient who developed a captopril-induced nephrotic syndrome, GFR dropped to 56% and CPAH to 50% of the control values. In another patient a transient rise in serum creatinine accompanied a severe drug reaction.
对10例严重高血压患者进行持续治疗,这些患者对先前治疗无反应,研究了每日高达450毫克卡托普利对血压和肾功能的影响。所有患者均持续服用利尿剂,大多数患者还服用β受体阻滞剂。在先前治疗期间进行了肾小球滤过率(GFR)和对氨基马尿酸清除率(CPAH)的对照测定。在平均25天(短期)和26周(长期)后评估添加(或替代)卡托普利的效果。短期治疗使平均血压降低了15.5%,对肾功能的个体间影响各不相同。平均而言,GFR略低于对照值,CPAH略高于对照值(无统计学意义)。这种模式与大多数其他抗高血压药物的效果非常相似。长期治疗时,GFR平均升高9%(无统计学意义),CPAH升高17%(p<0.02)。然而,有一名患者出现了卡托普利诱导的肾病综合征,GFR降至对照值的56%,CPAH降至对照值的50%。在另一名患者中,严重药物反应伴随血清肌酐短暂升高。